Preclinical, Regulatory, Clinical Trial Services
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,510
NCT02644889
EGFR Mutation Detection From Advanced NSCLC Patient Tissue and Plasma in EGFR-TKI Treatment
Phase: N/A
Role: Lead Sponsor
Start: Jan 31, 2016
Completion: Not specified
NCT02647164
The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring
NCT02653859
Evaluate the Auxiliary Diagnostic Value of Circulating Tumor Cells in Benign and Malignant Lung Nodules
NCT02661009
Human EGFR Mutations Quantitative Detection Kit (Real-time Fluorescent PCR Method)
Loading map...